Abstract Details
| Niels Borgstein, MD (Alkermes) | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Dawn M. Wilson (Biogen Idec UK & Ireland) | No disclosure on file |
| Eric Haltom (Biogen) | No disclosure on file |
| No disclosure on file | |
| Jasbir Seehra, PhD | Dr. Seehra has received personal compensation for serving as an employee of Keros Therapeutics. Dr. Seehra has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Modal Therapeutics. Dr. Seehra has or had stock in Keros Therapeutics. |
| Matthew L. Sherman, MD | No disclosure on file |